Printed From BioPortfolio.com
Lung cancer data gives Roche’s Tecentriq a boost
06:04 EST 21 Nov 2017 | PMLIVE
Will help its PD-L1 inhibitor compete with Merck & Co’s Keytruda
Original Article: Lung cancer data gives Roche’s Tecentriq a boost
Will help its PD-L1 inhibitor compete with Merck & Co’s Keytruda
Original Article: Lung cancer data gives Roche’s Tecentriq a boost
This site complies with the
HONcode standard for trustworthy health
information:
Verify here.
